Here are the top stories from the last week:

Industry Updates

Assessing RSV vaccine safety in older adults and pregnant patients
The article highlights the importance of monitoring and assessmentpost-approval for these patient groups.
Read article »

Knowledge gaps on kratom: building competence for patient counseling
This article explores the knowledge gaps pharmacists have regarding kratom,emphasizing the need for better education to guide patient counselingeffectively.
Read article »

Patient perceptions support co-management of chronic kidney disease
The article highlights a collaborative care model for chronic kidney disease, which improves patient education and management, leading to better outcomes.
Read article »

The critical role of pharmacists in managing Stiff Person Syndrome
This research article emphasizes the unique role pharmacists play in managing the symptoms and treatment of Stiff Person Syndrome.
Read article »

Considerations for the combined supplementation of Vitamins D and K
The article discusses how vitamins D and K work together to enhance bone strength and cardiovascular health, ensuring optimal calcium regulation.
Read article »

Costco pharmacies to stop offering abortion pill
The decision has drawn praise from religious investors and criticism from abortion rights supporters, as the battle over the pill shifts to CVS and Walgreens.
Read article »

FDA PreCheck program aims to boost U.S. drug manufacturing
"The FDA PreCheck initiative is one of many steps FDA is taking that can help reverse America's reliance on foreign drug manufacturing and ensure that Americans have a resilient, strong, and domestic drug supply."
Read article »

Cardinal Health announces the addition of Solaris Health
The deal adds over 750 providers to Cardinal Health's multi-specialty MSO platform, The Specialty Alliance.
Read article »

Drug & Treatment Updates

Azurity introduces Brynovin
Azurity Pharmaceuticals has launched Brynovin, an oral liquid sitagliptin, to manage Type 2 diabetes mellitus in adults. This product aims to improve glycemic control as an adjunct to diet and exercise, particularly benefiting those who have difficulty swallowing pills.
Read article »

Viatris receives FDA nod for generic Venofer injection
Viatris has received FDA approval for its generic version of Venofer, an iron sucrose injection used to treat iron deficiency anemia in patients with chronic kidney disease. This approval marks a significant advancement in providing affordable treatment options.
Read article »

Fresenius Kabi inks deal with Polpharma Biologics for Entyvio biosimilar
Fresenius Kabi has entered a licensing agreement with Polpharma Biologics to commercialize a biosimilar candidate for Entyvio, used in treating Crohn's disease and ulcerative colitis, expanding their biopharma portfolio.
Read article »

Alcon launches Tryptyr
Alcon has launched Tryptyr, a neuromodulator eye drop for dry eye disease, marking a significant innovation in the treatment space by rapidly increasing natural tear production.
Read article »

Kashiv BioSciences, MS Pharma ink deal for Xolair biosimilar
Kashiv BioSciences and MS Pharma have signed a deal for the biosimilar candidate to Xolair, focusing on the Middle East and North Africa region, aiming to expand access to innovative biologic therapies.
Read article »

‍